Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding.
暂无分享,去创建一个
Robert H. Jenkins | Timothy Bowen | A. Phillips | D. Fraser | Robert H Jenkins | John Martin | Aled O Phillips | Donald J Fraser | John Martin | T. Bowen
[1] Seongjoon Koo,et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. , 2004, Nucleic acids research.
[2] J. Iacomini,et al. Identification of a microRNA signature of renal ischemia reperfusion injury , 2010, Proceedings of the National Academy of Sciences.
[3] Jianxing He,et al. MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells , 2011, Nucleic acids research.
[4] H. Aburatani,et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats , 2003, Nuclear receptor.
[5] H. Aburatani,et al. Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4α in HepG2 Cells , 2011, The Journal of Biological Chemistry.
[6] Aimee L Jackson,et al. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.
[7] E. Bandrés,et al. miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation , 2010, Molecular Cancer Therapeutics.
[8] G. Goodall,et al. E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-β , 2010, Diabetes.
[9] A. Hattersley,et al. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] Mitsuo Kato,et al. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. , 2011, Kidney international.
[11] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[12] Huey-Jen Lin,et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. , 2010, Cancer cell.
[13] L. Wakefield,et al. Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. , 2002, The American journal of pathology.
[14] Mingyu Liang,et al. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. , 2008, Genome research.
[15] E. Li,et al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus , 2011, Lupus.
[16] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[17] R. Zager,et al. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.
[18] P. Igarashi,et al. Roles of HNF-1beta in kidney development and congenital cystic diseases. , 2005, Kidney international.
[19] Mitsuo Kato,et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[20] E. Abraham,et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. , 2011, American journal of physiology. Renal physiology.
[21] Kimihiro Hino,et al. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. , 2008, RNA.
[22] John J Rossi,et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors , 2007, Proceedings of the National Academy of Sciences.
[23] Robert H. Jenkins,et al. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.
[24] Gang Wang,et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. , 2010, American journal of hypertension.
[25] Xin Zhang,et al. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. , 2008, Cancer research.
[26] N. Farman,et al. Regulation of WNK1 expression by miR-192 and aldosterone. , 2010, Journal of the American Society of Nephrology : JASN.
[27] Remco Nagel,et al. The miRNA‐192/194 cluster regulates the Period gene family and the circadian clock , 2009, The FEBS journal.
[28] A. Phillips,et al. The Human Hyaluronan Synthase 2 (HAS2) Gene and Its Natural Antisense RNA Exhibit Coordinated Expression in the Renal Proximal Tubular Epithelial Cell♦ , 2011, The Journal of Biological Chemistry.
[29] Robert H. Jenkins,et al. A Conserved Stem Loop Motif in the 5′Untranslated Region Regulates Transforming Growth Factor-β1 Translation , 2010, PloS one.
[30] Bo Song,et al. miR-192 Regulates Dihydrofolate Reductase and Cellular Proliferation through the p53-microRNA Circuit , 2008, Clinical Cancer Research.
[31] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[32] B. Cullen. Transcription and processing of human microRNA precursors. , 2004, Molecular cell.
[33] Thomas Werner,et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..
[34] J. Long,et al. MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy* , 2011, The Journal of Biological Chemistry.
[35] Gang Wang,et al. Intrarenal expression of microRNAs in patients with IgA nephropathy , 2010, Laboratory Investigation.
[36] S. Lowe,et al. miR-19 is a key oncogenic component of mir-17-92. , 2009, Genes & development.
[37] J. Groffen,et al. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains , 2007, Nucleic acids research.
[38] Hui Zhou,et al. Liver‐enriched transcription factors regulate MicroRNA‐122 that targets CUTL1 during liver development , 2010, Hepatology.
[39] K. Bhatt,et al. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. , 2011, American journal of physiology. Renal physiology.
[40] L. Adorini,et al. Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model , 2010, Diabetes.
[41] Z. Saifudeen,et al. Transcriptional control of terminal nephron differentiation. , 2008, American journal of physiology. Renal physiology.
[42] Xiao-ming Meng,et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. , 2010, Journal of the American Society of Nephrology : JASN.
[43] J. Mendell. miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.